Profile: BioTelemetry Inc (BEAT.O)
BioTelemetry, Inc., incorporated on April 12, 2013, provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates through three segments: Healthcare, Technology and Research.
The Healthcare segment, operating as CardioNet, LLC (CardioNet) and Heartcare Corporation of America, Inc. (Heartcare), is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Company provides cardiologists and electrophysiologists with a range of solutions, ranging from its differentiated mobile cardiac telemetry (MCT) services to event and Holter monitoring. The Company also provides Pacemaker and International Normalized Ratio (INR) monitoring. The Company's Mobile Cardiac Outpatient Telemetry (MCOT) and External Cardiac Ambulatory Telemetry (ECAT) services incorporate a patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor. The monitor analyzes incoming heartbeat-by-heartbeat information from the sensor on a real-time basis by applying algorithms designed to detect arrhythmias. The monitor can detect an arrhythmic event even in the absence of symptoms noticed by the patient. When the monitor detects an arrhythmic event, it automatically transmits the ECG to its Monitoring Centers. At the Monitoring Centers, cardiac monitoring specialists analyze the sent data, respond to events and report results in the manner prescribed by the physician. The MCOT and ECAT devices employ two-way wireless communications, enabling continuous transmission of patient data to the Monitoring Centers and permitting physicians to remotely adjust monitoring parameters and request previous ECG data from the memory stored in the monitor. Its event monitoring services provide physicians with the flexibility to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors and non-loop event monitors. Its Holter monitor, the CardioKey, is a cardiac monitor, which continuously stores up to 14 days of cardiac images.
The Research segment, operating as Cardiocore, LLC (Cardiocore) and VirtualScopics, Inc. (VirtualScopics), is engaged in laboratory services that provide cardiac monitoring, imaging services, scientific consulting and data management services for drug, medical treatment and device trials. The services include ECG, Holter monitoring, ambulatory blood pressure monitoring (ABPM), echocardiography (ECHO), multigated acquisition scan (MUGA), a range of imaging services, protocol development, expert reporting and statistical analysis. The Company also provides a range of support services that include project coordination, setup and management, equipment rental, data transfer, processing, analysis and around the clock customer support and site training. The Company's data management systems enable customization for sponsors' preferred data specifications and its Web service, CardioPortal, provides access to data from any Web browser, without client-side plug-ins. Its customers are pharmaceutical companies and contract research organizations. It operates locations in Maryland, California, New York; London, the United Kingdom, and Tokyo, Japan, which support sponsors and sites in Eastern and Western Europe, Russia and Asia-Pacific, North and South America, Africa and the Middle East.
The Technology segment, operating as Braemar Manufacturing, LLC (Braemar), Universal Medical, Inc. (UMI) and BioTelemetry Belgium BVBA. (BioTelemetry Belgium) and BioTelemetry Technology ApS (BioTelemetry Denmark), focuses on the manufacturing, engineering and development of noninvasive cardiac monitors for healthcare companies around the world. The Company offers contract manufacturing services, developing and producing devices to the specific requirements set by customers. Braemar and UMI manufacture the cardiac monitoring devices utilized by its Healthcare segment. Braemar and UMI manufacture various devices, including cardiac event monitors, digital Holter monitors and mobile cardiac telemetry monitors. It operates BioTelemetry Belgium in Zaventem, Belgium, which imports and distributes its devices to the international markets. It also operates BioTelemetry Denmark, manufactures and sells devices to customers in the international market. Its wireless Blood Glucose Monitoring (BGM) system transmits real-time results to a cloud-based analytical engine, which synthesizes the data, monitors trends and provides caregivers with information about the patients' health status and the need to intervene.
1000 Cedar Hollow Rd
MALVERN PA 19355-2300